Cargando…

Designing phase I oncology dose escalation using dose–exposure–toxicity models as a complementary approach to model‐based dose–toxicity models

One of the objectives of oncology phase I dose‐escalation studies has been to determine the maximum tolerated dose (MTD). Although MTD is no longer set as the dose for further development in contemporary oncology drug development, MTD determination is still important for informing the therapeutic in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pantoja, Kristyn, Lanke, Shankar, Munafo, Alain, Victor, Anja, Habermehl, Christina, Schueler, Armin, Venkatakrishnan, Karthik, Girard, Pascal, Goteti, Kosalaram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574748/ https://www.ncbi.nlm.nih.gov/pubmed/35852048 http://dx.doi.org/10.1002/psp4.12851

Ejemplares similares

518. Model-informed Dose Selection of Dual Toll-like Receptor 7/8 Inhibitor Enpatoran (M5049) for the Treatment of COVID-19 Pneumonia
por: Klopp-Schulze, Lena, et al.
Publicado: (2021)

Applying Modeling and Simulations for Rational Dose Selection of Novel Toll‐Like Receptor 7/8 Inhibitor Enpatoran for Indications of High Medical Need
por: Klopp‐Schulze, Lena, et al.
Publicado: (2022)

Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer
por: Rosenbrock, Johannes, et al.
Publicado: (2023)

Characterization of a developmental toxicity dose-response model.
por: Faustman, E M, et al.
Publicado: (1989)

Comparison of Various Phase I Combination Therapy Designs in Oncology for Evaluation of Early Tumor Shrinkage Using Simulations
por: Seurat, Jérémy, et al.
Publicado: (2020)

Generating Modeling Data From Repeat-Dose Toxicity Reports
por: López-Massaguer, Oriol, et al.
Publicado: (2018)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017)

PK/PD modeling supports the dose-escalation decision in VIKING
por: Lovern, M, et al.
Publicado: (2010)

Monte Carlo Models for Sub-Chronic Repeated-Dose Toxicity: Systemic and Organ-Specific Toxicity
por: Selvestrel, Gianluca, et al.
Publicado: (2022)

Phase I Radiation Dose-Escalation Study to Investigate the Dose-Limiting Toxicity of Concurrent Intra-Arterial Chemotherapy for Unresectable Hepatocellular Carcinoma
por: Cho, Yeona, et al.
Publicado: (2020)

Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer()
por: Warren, Samantha, et al.
Publicado: (2014)

Dose-Response Modeling with Summary Data from Developmental Toxicity Studies
por: Fox, John F., et al.
Publicado: (2016)

A Toxic Dose of Belladonna
por: Gibbons, H.
Publicado: (1884)

Addressing the barriers to implementing model based designs in dose escalation studies
por: Cornelius, Victoria, et al.
Publicado: (2015)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
por: Carrington, Rhys, et al.
Publicado: (2015)

Recommendations on dose level selection for repeat dose toxicity studies
por: Sewell, Fiona, et al.
Publicado: (2022)

Phenytoin Toxicity with High Dose, Concomitant Ascorbic Acid Dosing
por: Schuh, Michael J., et al.
Publicado: (2022)

Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens
por: Gerard, Emma, et al.
Publicado: (2021)

Physiologically‐Based Pharmacokinetic Models as Enablers of Precision Dosing in Drug Development: Pivotal Role of the Human Mass Balance Study
por: Rowland Yeo, Karen, et al.
Publicado: (2020)

Dose-Dependent Response to Cyclodextrin Infusion in a Rat Model of Verapamil Toxicity
por: Mottram, Allan R, et al.
Publicado: (2012)

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
por: Holyoake, Daniel L.P., et al.
Publicado: (2017)

Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity
por: Benest, John, et al.
Publicado: (2022)

Single-Dose Intramuscular Toxicity of Mahwangcheonoh Pharmacopuncture in a Rat Model: - Toxicity of Mahwangcheonoh Pharmacopuncture in SD Rats -
por: Sung, Heejin, et al.
Publicado: (2016)

Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer
por: Crezee, J., et al.
Publicado: (2016)

Model-Informed Development of Sotalol Loading and Dose Escalation Employing an Intravenous Infusion
por: Somberg, John C., et al.
Publicado: (2020)

Exposure–response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations
por: Xiong, Wenyuan, et al.
Publicado: (2022)

Intensity Modulated Radiation Therapy for Retroperitoneal Sarcoma: A Case for Dose Escalation and Organ at Risk Toxicity Reduction
por: Koshy, Mary, et al.
Publicado: (2003)

A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity
por: Gibb, A, et al.
Publicado: (2013)

Toxic Responses Induced at High Doses May Affect Benchmark Doses
por: Zarn, Jürg A., et al.
Publicado: (2020)

Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control
por: Petrongari, Maria Grazia, et al.
Publicado: (2013)

A multistate modeling and simulation framework to learn dose–response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer
por: Liu, Han, et al.
Publicado: (2023)

Dose escalation of a curcuminoid formulation
por: Lao, Christopher D, et al.
Publicado: (2006)

Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient‐level placebo (Standard‐of‐Care) data to enable model‐informed drug development
por: Goteti, Kosalaram, et al.
Publicado: (2022)

Dose Escalation of Vitamin D(3) Yields Similar Cryosurgical Outcome to Single Dose Exposure in a Prostate Cancer Model
por: Santucci, Kimberly L., et al.
Publicado: (2018)

Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
por: Kim, Jun Won, et al.
Publicado: (2017)

Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)
por: Al-Mamgani, Abrahim, et al.
Publicado: (2023)

Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial
por: Bhargava, Mudit, et al.
Publicado: (2023)

Bevacizumab Arrests Osteoarthritis Progression in a Rabbit Model: A Dose-Escalation Study
por: Vadalà, Gianluca, et al.
Publicado: (2021)

Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking
por: Ghadjar, Pirus, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_pinp2uk4h0cuvkcbsfsl11snks